-
-
-
-
-
-
-
Adaptimmune (ADAP) and TCR2 (TCRR) to Merge
-
-
-
-
-
-
-
TCR² Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TCR2 Therapeutics (TCRR) PT Lowered to $44 at BMO Capital, Following Earnings
-
-
-
-
-
-
-
TCR² Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TCR2 Therapeutics (TCRR) Reports Q1 Loss of $4.85
-
-
-
-
-
975,688 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All